HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+15.22%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$280M
AUM Growth
+$280M
(+1.8%)
Cap. Flow
-$16.9M
Cap. Flow
% of AUM
-6.04%
Top 10 Holdings %
Top 10 Hldgs %
28.7%
Holding
166
New
40
Increased
28
Reduced
35
Closed
35
Top Buys
| 1 |
Apogee Therapeutics
APGE
|
$7.93M |
| 2 |
ANSS
Ansys
ANSS
|
$4.44M |
| 3 |
JNPR
Juniper Networks
JNPR
|
$4.25M |
| 4 |
VanEck Gold Miners ETF
GDX
|
$2.78M |
| 5 |
Keros Therapeutics
KROS
|
$2.6M |
Top Sells
| 1 |
Spyre Therapeutics
SYRE
|
$16.1M |
| 2 |
Immunovant
IMVT
|
$5.11M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$4.29M |
| 4 |
SPLK
Splunk Inc
SPLK
|
$4.2M |
| 5 |
SOVO
Sovos Brands, Inc. Common Stock
SOVO
|
$4.07M |
Sector Composition
| 1 | Healthcare | 44.78% |
| 2 | Technology | 11.84% |
| 3 | Consumer Discretionary | 7.8% |
| 4 | Industrials | 6.17% |
| 5 | Financials | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
| $33M | 11.76% | 1,436,136 | – | – |
|
|
2
Apogee Therapeutics
APGE
$2.17B
| $7.93M | 2.83% | +119,403 | New | +$7.93M |
|
|
3
Spyre Therapeutics
SYRE
$996M
| $5.86M | 2.09% | 154,381 -423,235 | -73% | -$16.1M |
|
4
Merus
MRUS
$4.98B
| $5.48M | 1.95% | 121,680 -11,892 | -9% | -$535K |
|
5
Microsoft
MSFT
$3.77T
| $5.16M | 1.84% | 12,258 -2,200 | -15% | -$926K |
|
6
Arcellx
ACLX
$3.85B
| $5.02M | 1.79% | 72,230 | – | – |
|
7
XPO
XPO
$15.3B
| $4.68M | 1.67% | 38,380 +12,400 | +48% | +$1.51M |
|
8
Nuvalent
NUVL
$5.52B
| $4.51M | 1.61% | 60,011 +5,928 | +11% | +$445K |
|
|
ANSS
9
DELISTED
Ansys
ANSS
| $4.44M | 1.58% | +12,800 | New | +$4.44M |
|
|
HES
10
DELISTED
Hess
HES
| $4.41M | 1.57% | 28,900 | – | – |
|
11
IDEAYA Biosciences
IDYA
$2.15B
| $4.36M | 1.55% | 99,292 -27,553 | -22% | -$1.21M |
|
|
JNPR
12
DELISTED
Juniper Networks
JNPR
| $4.25M | 1.52% | +114,700 | New | +$4.25M |
|
|
SP
13
DELISTED
SP Plus Corporation
SP
| $4.12M | 1.47% | 78,900 | – | – |
|
|
CERE
14
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $4.11M | 1.47% | 97,200 | – | – |
|
15
Albertsons Companies
ACI
$10.9B
| $4.05M | 1.44% | 188,753 | – | – |
|
|
BCYC
16
Bicycle Therapeutics
BCYC
$511M
| $3.94M | 1.41% | 158,293 | – | – |
|
17
Axsome Therapeutics
AXSM
$6.05B
| $3.87M | 1.38% | 48,527 -13,736 | -22% | -$1.1M |
|
18
Indivior
INDV
$3.03B
| $3.82M | 1.36% | 178,836 +13,995 | +8% | +$299K |
|
19
Salesforce
CRM
$245B
| $3.82M | 1.36% | 12,679 -2,300 | -15% | -$693K |
|
20
Amazon
AMZN
$2.44T
| $3.62M | 1.29% | 20,093 +12,300 | +158% | +$2.22M |
|
|
AMED
21
DELISTED
Amedisys
AMED
| $3.62M | 1.29% | 39,250 | – | – |
|
22
Capri Holdings
CPRI
$2.45B
| $3.52M | 1.26% | 77,700 | – | – |
|
23
Viridian Therapeutics
VRDN
$1.5B
| $3.48M | 1.24% | 198,484 | – | – |
|
24
Insmed
INSM
$28.8B
| $3.44M | 1.23% | 126,780 | – | – |
|
25
Xenon Pharmaceuticals
XENE
$2.98B
| $3.13M | 1.12% | 72,715 +20,914 | +40% | +$900K |
|